August 20, 2018 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) sold BioCryst Pharmaceuticals, Inc., a stock transaction, valued at $1,000 - $15,000. The trade took place on August 20, 2018 and was disclosed on September 5, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.